Trials / Completed
CompletedNCT01739673
Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Cxlusa · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ultraviolet-A and riboflavin |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2012-12-03
- Last updated
- 2018-09-26
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01739673. Inclusion in this directory is not an endorsement.